Sensera selected by Autodesk to showcase technology
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Internet of Things solutions provider Sensera Limited (ASX:SE1) has been selected by Autodesk (NASDAQ:ADSK) to participate in its Residency Program at its Technology Center in Boston, Massachusetts.
As a backdrop, Sensera delivers sensor-based products transforming real-time data into meaningful information, action and value.
The company designs and manufactures hardware and software across the vertical technology spectrum from unique structures as MicroElectroMechanical Systems (MEMS) and sensors, as well as wireless networked systems and software that when combined, drive an entire IoT platform solution.
The network of Autodesk Technology Centers in San Francisco, Boston, Toronto and Birmingham, UK brings together industry, academic, and entrepreneurial communities to create a shared vision of the future of making.
Autodesk generates annual revenues of US$3.2 billion
Autodesk is a major player in an industry closely aligned with Sensera, and the group generates more than US$3.2 billion in annual revenue.
Sensera’s IoT location awareness solutions came shortly after the company signed a global distribution deal with NYSE-listed Arrow Electronics.
The following shows one of the company’s location tracking tags on a crane at the Boston Autodesk Technology Center.
Meanwhile, SE1’s fiscal 2020 revenues and order book are building well after the group grew income by 60% to US$10.2 million in fiscal 2019.
The Microdevices and IoT Solutions business units increased revenues by approximately 75% and 54%, respectively.
Close to 50% of the total revenue related to contracts executed in fiscal 2018 with Smartbow (now Zoetis) and Abiomed, and these will continue to provide a substantial contribution to revenues into fiscal 2020.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
